Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Oct 01, 2012
Acting Chief Financial Officer
Acting Chief Financial Officer Open market or private sale of non-derivative or derivative security 6,000 $12.00
Sep 07, 2012
Acting Chief Financial Officer
Acting Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Dec 23, 2011
Acting Chief Financial Officer
Acting Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 86,500 $14.77
Dec 23, 2011
Acting Chief Financial Officer
Acting Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 40,179 $14.77
Jun 12, 2011
Acting Chief Financial Officer
Acting Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jan 20, 2011
Acting Chief Financial Officer
Acting Chief Financial Officer Open market or private purchase of non-derivative or derivative security 4,000 $6.05
Oct 11, 2010
Acting Chief Financial Officer
Acting Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 03, 2013
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Dec 03, 2013
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 60,000 --
Apr 20, 2013
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --
Apr 20, 2013
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --
Apr 20, 2013
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --
Apr 20, 2013
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --
Sep 07, 2012
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Dec 23, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 86,500 $14.77
Dec 23, 2011
Chief Commercial Officer
Chief Commercial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 36,719 $14.77
Nov 29, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 30, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,000 --
Jun 12, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
May 03, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Jan 03, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jan 03, 2011
Chief Commercial Officer
Chief Commercial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Dec 23, 2010
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --
Dec 23, 2010
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --
Dec 23, 2010
Chief Commercial Officer
Chief Commercial Officer Initial Statement of Beneficial Ownership of Securities -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.